January 28th, 2005 - Volume 19 - Issue 2
pp: 105-220




Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results

Kashuba, Angela DM; Tierney, Camlin; Downey, Gerald F; More

AIDS. 19(2):145-152, January 28th, 2005.

Concise Communication



Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs

Ananworanich, Jintanat; Moor, Zewlan; Siangphoe, Umaporn; More

AIDS. 19(2):185-192, January 28th, 2005.